A series of triazole-containing novobiocin analogues has been designed, synthesized and their inhibitory activity determined. These compounds contain a triazole ring in lieu of the amide moiety present in the natural product. The anti-proliferative effects of these compounds were evaluated against two breast cancer cell lines (SKBr-3 and MCF-7), and manifested activities similar to their amide-containing counterparts. In addition, Hsp90-dependent client protein degradation was observed via western blot analysis, further supporting a common mode of Hsp90 inhibition for both structural classes
The heat shock protein 90 (Hsp90) folding machinery is essential for the maturation of nascent polyp...
Novobiocin, a known DNA gyrase inhibitor, binds to a nucleotide-binding site located on the Hsp90 C-...
As C−terminal inhibitors of a 90−kDa heat shock protein (Hsp90), novobiocin and its deri...
Hsp90 C-terminal inhibitors are advantageous for the development of new cancer chemotherapeutics due...
Hsp90 is a promising therapeutic target for the treatment of cancer. Novobiocin is the first Hsp90 C...
Dissertation (Ph.D.)--University of Kansas, Medicinal Chemistry, 2007.The 90 kDa heat shock proteins...
Since Hsp90 modulates all six hallmarks of cancer simultaneously, it has become an attractive target...
Novobiocin analogs lacking labile glycosidic ether have been designed, synthesized and evaluated for...
Development of heat shock protein 90 (Hsp90) C‐terminal inhibitors has emerged as an exciting strate...
This document is the Accepted Manuscript version of a Published Work that appeared in final form in ...
none35noRuthenium catalyzed 1,3-cycloaddition (click chemistry) of an azido moiety installed on dihy...
Modulation of Hsp90 C-terminal function represents a promising therapeutic approach for the treatmen...
Hsp90 C-terminal inhibitors represent a novel and alternative chemotherapeutic approach for the trea...
Ruthenium catalyzed 1,3-cycloaddition (click chemistry) of an azido moiety installed on dihydroxycum...
The research described in this thesis focuses on heat shock protein 90 kDa (Hsp90), which is a molec...
The heat shock protein 90 (Hsp90) folding machinery is essential for the maturation of nascent polyp...
Novobiocin, a known DNA gyrase inhibitor, binds to a nucleotide-binding site located on the Hsp90 C-...
As C−terminal inhibitors of a 90−kDa heat shock protein (Hsp90), novobiocin and its deri...
Hsp90 C-terminal inhibitors are advantageous for the development of new cancer chemotherapeutics due...
Hsp90 is a promising therapeutic target for the treatment of cancer. Novobiocin is the first Hsp90 C...
Dissertation (Ph.D.)--University of Kansas, Medicinal Chemistry, 2007.The 90 kDa heat shock proteins...
Since Hsp90 modulates all six hallmarks of cancer simultaneously, it has become an attractive target...
Novobiocin analogs lacking labile glycosidic ether have been designed, synthesized and evaluated for...
Development of heat shock protein 90 (Hsp90) C‐terminal inhibitors has emerged as an exciting strate...
This document is the Accepted Manuscript version of a Published Work that appeared in final form in ...
none35noRuthenium catalyzed 1,3-cycloaddition (click chemistry) of an azido moiety installed on dihy...
Modulation of Hsp90 C-terminal function represents a promising therapeutic approach for the treatmen...
Hsp90 C-terminal inhibitors represent a novel and alternative chemotherapeutic approach for the trea...
Ruthenium catalyzed 1,3-cycloaddition (click chemistry) of an azido moiety installed on dihydroxycum...
The research described in this thesis focuses on heat shock protein 90 kDa (Hsp90), which is a molec...
The heat shock protein 90 (Hsp90) folding machinery is essential for the maturation of nascent polyp...
Novobiocin, a known DNA gyrase inhibitor, binds to a nucleotide-binding site located on the Hsp90 C-...
As C−terminal inhibitors of a 90−kDa heat shock protein (Hsp90), novobiocin and its deri...